MINDBODY (MB) Cut to “Market Perform” at Wells Fargo & Co

MINDBODY (NASDAQ:MB) was downgraded by stock analysts at Wells Fargo & Co from an “outperform” rating to a “market perform” rating in a note issued to investors on Monday, The Fly reports.

A number of other analysts have also commented on the company. Zacks Investment Research lowered MINDBODY from a “hold” rating to a “sell” rating in a report on Wednesday, December 5th. BidaskClub lowered MINDBODY from a “hold” rating to a “sell” rating in a report on Saturday, February 2nd. TheStreet raised MINDBODY from a “d+” rating to a “c-” rating in a report on Thursday, January 24th. Imperial Capital decreased their price objective on MINDBODY from $42.00 to $36.00 and set an “outperform” rating for the company in a report on Thursday, November 8th. Finally, JMP Securities lowered MINDBODY from an “outperform” rating to a “market perform” rating and set a $36.42 price objective for the company. in a report on Thursday, January 24th. One research analyst has rated the stock with a sell rating, twelve have issued a hold rating, three have issued a buy rating and one has issued a strong buy rating to the company. The stock currently has an average rating of “Hold” and a consensus price target of $36.29.

Shares of NASDAQ:MB traded down $0.05 during midday trading on Monday, reaching $36.46. The company’s stock had a trading volume of 124,826 shares, compared to its average volume of 1,437,768. The company has a market capitalization of $1.75 billion, a price-to-earnings ratio of -121.53 and a beta of -0.35. The company has a debt-to-equity ratio of 0.89, a current ratio of 9.45 and a quick ratio of 9.45. MINDBODY has a fifty-two week low of $21.61 and a fifty-two week high of $45.50.

In other MINDBODY news, CFO Brett T. White sold 10,000 shares of the stock in a transaction on Monday, December 24th. The stock was sold at an average price of $36.32, for a total transaction of $363,200.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Richard Lee Stollmeyer sold 17,739 shares of the stock in a transaction on Monday, December 3rd. The shares were sold at an average price of $27.85, for a total value of $494,031.15. The disclosure for this sale can be found here. Over the last three months, insiders have sold 57,427 shares of company stock valued at $1,936,999. 6.02% of the stock is owned by corporate insiders.

Large investors have recently bought and sold shares of the business. AdvisorNet Financial Inc purchased a new stake in shares of MINDBODY during the fourth quarter worth $36,000. Bank of Montreal Can raised its position in shares of MINDBODY by 147.9% in the fourth quarter. Bank of Montreal Can now owns 1,014 shares of the technology company’s stock worth $37,000 after buying an additional 605 shares in the last quarter. D.A. Davidson & CO. purchased a new stake in shares of MINDBODY in the third quarter worth $201,000. GAM Holding AG purchased a new stake in shares of MINDBODY in the fourth quarter worth $207,000. Finally, Whetstone Capital Advisors LLC purchased a new stake in shares of MINDBODY in the third quarter worth $232,000.

About MINDBODY

MINDBODY, Inc operates a cloud-based business management software and payments platform for the small and medium-sized businesses in the wellness services industry. Its platform enables businesses to run, market, and build scheduling and online booking, performance tracking, staff management, client relationship management, integrated payment processing, retail point-of-sale, purchase tracking, inventory, hardware integration, analytics and reporting, branded Web, mobility, social integration, client acquisition dashboard, security and compliance, and integration with other cloud-based partners for yoga, Pilates, indoor cycling, group and personal training, boutique fitness, salons, spas, and integrative health businesses.

Further Reading: QQQ ETF

The Fly

Analyst Recommendations for MINDBODY (NASDAQ:MB)

Receive News & Ratings for MINDBODY Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MINDBODY and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply